搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
clinicaltrialsarena
12 小时
Syndax’s stock sinks by 25% despite AML trial meeting primary endpoint
Despite this success, investors were unimpressed with the topline data, with Syndax’s stock dropping by 25.6%, from $21.78 ...
clinicaltrialsarena
12 小时
Poor posterior occlusion identified as a new risk factor for dementia
Medical advances and better knowledge of health have contributed to increased life expectancy and a growing elderly ...
clinicaltrialsarena
12 小时
Kezar struck again with second FDA hold
They say lightning rarely strikes twice but Kezar Life Sciences has suffered its second clinical blow in as many months.
clinicaltrialsarena
13 小时
The development of novel drugs: the role of lyophilization
Lyophilization plays a crucial role in successful biologic molecule development, but what is lyophilization – and how can it ...
clinicaltrialsarena
17 小时
Longboard commences Phase III trial of bexicaserin for DEEs seizure treatment
Longboard has commenced the Phase III DEEp OCEAN Study of bexicaserin for treating seizures linked to DEEs in two years and ...
clinicaltrialsarena
22 小时
How logistics shape the success of rare disease trials
At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈